Aehr Test Systems (NASDAQ:AEHR) Trading 8.1% Higher – Still a Buy?

Aehr Test Systems (NASDAQ:AEHR)’s share price traded up 8.1% during mid-day trading on Friday . The company traded as high as $31.32 and last traded at $32.7190. 126,707 shares were traded during trading, a decline of 90% from the average session volume of 1,312,105 shares. The stock had previously closed at $30.27.

Analyst Ratings Changes

Several analysts have recently commented on the stock. Weiss Ratings restated a “sell (d)” rating on shares of Aehr Test Systems in a research report on Wednesday, January 21st. Craig Hallum restated a “hold” rating on shares of Aehr Test Systems in a research report on Friday, January 9th. Zacks Research raised Aehr Test Systems from a “strong sell” rating to a “hold” rating in a research report on Monday, December 8th. Finally, Lake Street Capital began coverage on shares of Aehr Test Systems in a research note on Wednesday, December 17th. They issued a “buy” rating for the company. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $21.00.

Aehr Test Systems Trading Up 11.0%

The company’s 50-day moving average is $25.65 and its 200 day moving average is $25.06. The stock has a market capitalization of $1.03 billion, a PE ratio of -112.00 and a beta of 2.31.

Aehr Test Systems (NASDAQ:AEHR) last announced its quarterly earnings data on Thursday, January 8th. The semiconductor company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.04. The firm had revenue of $9.88 million for the quarter, compared to analyst estimates of $11.45 million. Aehr Test Systems had a negative net margin of 16.63% and a negative return on equity of 4.57%. Sell-side analysts forecast that Aehr Test Systems will post 0.1 EPS for the current fiscal year.

Insider Activity

In other news, Director Laura Oliphant sold 4,546 shares of the business’s stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $31.40, for a total value of $142,744.40. Following the completion of the transaction, the director owned 18,432 shares of the company’s stock, valued at $578,764.80. The trade was a 19.78% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Rhea J. Posedel sold 13,998 shares of the company’s stock in a transaction that occurred on Friday, February 13th. The stock was sold at an average price of $30.02, for a total value of $420,219.96. Following the completion of the sale, the director owned 456,979 shares in the company, valued at approximately $13,718,509.58. This represents a 2.97% decrease in their position. The disclosure for this sale is available in the SEC filing. 6.80% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Aehr Test Systems

A number of institutional investors have recently added to or reduced their stakes in the stock. ARS Investment Partners LLC acquired a new position in Aehr Test Systems in the 2nd quarter valued at $300,000. Bosun Asset Management LLC purchased a new position in shares of Aehr Test Systems during the 2nd quarter worth $272,000. AlphaQuest LLC increased its holdings in Aehr Test Systems by 697.6% in the 2nd quarter. AlphaQuest LLC now owns 20,156 shares of the semiconductor company’s stock valued at $261,000 after purchasing an additional 17,629 shares during the last quarter. Pier Capital LLC lifted its stake in Aehr Test Systems by 16.0% during the 2nd quarter. Pier Capital LLC now owns 405,932 shares of the semiconductor company’s stock worth $5,249,000 after acquiring an additional 55,861 shares in the last quarter. Finally, Kennedy Capital Management LLC acquired a new stake in shares of Aehr Test Systems during the second quarter worth about $5,751,000. Institutional investors and hedge funds own 69.69% of the company’s stock.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.